REG - Cavendish Financial - AGM Trading Statement

Cenkos SecuritiesAnnouncement

29/09/2023 08:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230929:nRSc0410Oa&default-theme=true

RNS Number : 0410O  Cavendish Financial PLC  29 September 2023

29 September 2023

For immediate Release

 

Cavendish Financial plc ("Cavendish" or the "Group")

AGM Trading Statement

Cavendish Financial plc announces the following update ahead of its Annual
General Meeting to be held today at 10.00 am:

On 8 September, finnCap Group plc and Cenkos Securities plc completed their
merger to create Cavendish Financial plc, a full-service investment bank for
ambitious growth companies.

The combined operation consists of just under 200 people operating from its
headquarters in One Bartholomew Close, London and its Scottish office in
Edinburgh.   With 220 quoted clients, the Group has the largest retained
client base amongst UK small and midcap investment banks, making it the go-to
financial advisory firm for growth and investment companies.   In addition
to equity capital markets, Cavendish has expertise in M&A, debt advisory
and private growth capital. The Group also has a strong global reach through
its membership of Oaklins, an international advisory network.

 

Since the merger, the Group has relocated all of the London based Cenkos team
to its London headquarters, launched the new operating brand Cavendish,
centralised trading onto a single platform and made substantial progress with
its IT integration.  The integration of the operations team, a key part of
delivering the synergies is also nearing completion.  The Group will provide
a further update on synergy realisation within its inaugural interim results
expected to be announced in December.

 

Trading across the City has been quiet during the Summer, but since merger
completion the Group has already announced a number of significant
transactions which will close in the coming months including acting as sole
adviser to Round Hill Royalty Fund Limited on its offer from Concord Cadence
Limited, fundraisings for Haydale Graphene PLC and Shield Therapeutics plc and
obtaining key regulatory clearances for the equity financing of Allergy
Therapeutics by ZQ Capital and Southern Fox.

 

Contacts:

 

Cavendish Financial
plc
                Tel: +44 (0)20 7220 0500

John Farrugia, co-CEO

Julian Morse, co-CEO

 

Grant Thorton UK LLP (Nominated Adviser to Cavendish)
                      Tel: +44 (0)20 7383 5100

Philip Secrett/Samantha Harrison/Samuel Littler

Hudson Sandler (PR adviser to Cavendish)

Dan de Belder
 
                  Tel: +44 (0) 7977 927142

Rebekah Chapman
 
           Tel: +44 (0) 7702 596674

 

 

About Cavendish

Cavendish is a UK champion for ambitious growth and investment companies. The
Group is trusted by public and private companies, operating across industry
sectors, to deliver expert services in equity capital markets, M&A, debt
advisory and growth capital.

 

Cavendish has offices in the City of London and Edinburgh and has a global
reach through its membership of Oaklins. Cavendish Financial plc is quoted on
AIM.

 

For more information on Cavendish, please visit www.cavendish.com
(https://clicktime.symantec.com/15t5ZtiMMcNgioT1GjMW2?h=-1ddyUfQMCx-ar6oi5goqZU3AnOgmhiDIsb1UjL2zh4=&u=http://www.cavendish.com/)

 

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  AGMUWROROUUKUAR